Morse Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Morse Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,400	Closed	-$772K	–	138
2019 Q1	$772K	Sell	5,400 -600	-10%	-$78.3K	0.23%	83
2018 Q4	$744K	Sell	6,000 -13,620	-69%	-$2.02M	0.26%	74
2018 Q3	$3.3M	Sell	19,620 -225	-1%	-$38.7K	0.87%	36
2018 Q2	$3.42M	Sell	19,845 -270	-1%	-$44.1K	0.94%	33
2018 Q1	$3.04M	Sell	20,115 -1,375	-6%	-$202K	0.84%	37
2017 Q4	$2.89M	Sell	21,490 -6,070	-22%	-$842K	0.81%	41
2017 Q3	$4.03M	Sell	27,560 -610	-2%	-$92.3K	1.2%	28
2017 Q2	$4.38M	Buy	28,170 +1,215	+5%	+$186K	1.43%	21
2017 Q1	$3.91M	Buy	+26,955	New	+$3.51M	1.33%	21

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Morse Asset Management's JAZZ Position: Q2 2019 in Review

Morse Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2019, closing a stake of 5,400 shares — an estimated $772K sold.

Morse Asset Management first reported a position in JAZZ in Q1 2017 and held it in 9 quarters. The position peaked at $4.38M in Q2 2017. 416 funds tracked by Wall St. Rank hold JAZZ as of Q2 2019.

Morse Asset Management reported no remaining Jazz Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Morse Asset Management sold 5,400 Jazz Pharmaceuticals shares in Q2 2019, an estimated $772K.
Morse Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 9 quarters.
Morse Asset Management's Jazz Pharmaceuticals position peaked at $4.38M in Q2 2017.
416 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2019.

Based on Morse Asset Management's 13F filing for Q2 2019, filed 1 Aug 2019.